Concepts (268)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Insulin-Secreting Cells | 5 | 2018 | 273 | 1.41 | Why? |
| Sitagliptin Phosphate | 2 | 2019 | 82 | 1.38 | Why? |
| Diabetes Mellitus, Type 2 | 15 | 2020 | 6166 | 1.31 | Why? |
| Insulin Glargine | 3 | 2019 | 43 | 1.10 | Why? |
| Diabetes Mellitus, Type 1 | 7 | 2021 | 1969 | 1.02 | Why? |
| Insulin | 8 | 2018 | 1316 | 1.01 | Why? |
| Metformin | 3 | 2019 | 640 | 0.96 | Why? |
| Kruppel-Like Transcription Factors | 1 | 2021 | 91 | 0.85 | Why? |
| Blood Glucose | 12 | 2020 | 3642 | 0.82 | Why? |
| Human Umbilical Vein Endothelial Cells | 1 | 2021 | 286 | 0.78 | Why? |
| Hypoglycemic Agents | 6 | 2019 | 2165 | 0.77 | Why? |
| Liraglutide | 1 | 2019 | 47 | 0.76 | Why? |
| Insulin Resistance | 5 | 2018 | 669 | 0.75 | Why? |
| Diabetic Neuropathies | 1 | 2018 | 64 | 0.72 | Why? |
| Venoms | 1 | 2017 | 24 | 0.70 | Why? |
| Glycated Hemoglobin A | 6 | 2018 | 1316 | 0.64 | Why? |
| Sirtuin 1 | 1 | 2017 | 100 | 0.63 | Why? |
| Diabetes Mellitus, Experimental | 1 | 2018 | 192 | 0.61 | Why? |
| Endoplasmic Reticulum Stress | 2 | 2018 | 253 | 0.61 | Why? |
| Cardiovascular Agents | 1 | 2021 | 663 | 0.57 | Why? |
| Heat-Shock Proteins | 1 | 2017 | 226 | 0.55 | Why? |
| Fatty Liver | 1 | 2017 | 299 | 0.51 | Why? |
| Bibliometrics | 1 | 2021 | 731 | 0.51 | Why? |
| Fasting | 1 | 2018 | 555 | 0.50 | Why? |
| Atherosclerosis | 1 | 2021 | 768 | 0.50 | Why? |
| Hyperglycemia | 2 | 2020 | 1363 | 0.47 | Why? |
| Diabetes Mellitus | 5 | 2018 | 8207 | 0.43 | Why? |
| Endothelium, Vascular | 1 | 2021 | 1751 | 0.40 | Why? |
| Non-alcoholic Fatty Liver Disease | 1 | 2019 | 907 | 0.39 | Why? |
| Biomedical Research | 2 | 2021 | 5270 | 0.38 | Why? |
| Gliclazide | 2 | 2018 | 13 | 0.36 | Why? |
| Mucocutaneous Lymph Node Syndrome | 1 | 2020 | 1645 | 0.36 | Why? |
| Periodicals as Topic | 1 | 2021 | 1492 | 0.35 | Why? |
| Curcumin | 3 | 2017 | 396 | 0.34 | Why? |
| Medicine, Chinese Traditional | 2 | 2021 | 2255 | 0.33 | Why? |
| Diet, High-Fat | 2 | 2017 | 161 | 0.31 | Why? |
| Hypoglycemia | 3 | 2021 | 406 | 0.30 | Why? |
| Peptides | 1 | 2017 | 2513 | 0.29 | Why? |
| MicroRNAs | 1 | 2018 | 1787 | 0.28 | Why? |
| Hepatocytes | 2 | 2017 | 549 | 0.27 | Why? |
| Cytokines | 3 | 2021 | 15010 | 0.27 | Why? |
| Early Diagnosis | 3 | 2018 | 2443 | 0.26 | Why? |
| Blood Glucose Self-Monitoring | 2 | 2021 | 791 | 0.26 | Why? |
| Lipid Metabolism | 2 | 2019 | 572 | 0.25 | Why? |
| Transcription Factors | 2 | 2020 | 784 | 0.25 | Why? |
| Thyroglobulin | 2 | 2019 | 39 | 0.24 | Why? |
| Vascular Cell Adhesion Molecule-1 | 1 | 2021 | 121 | 0.22 | Why? |
| Evidence-Based Medicine | 1 | 2014 | 3228 | 0.22 | Why? |
| Drug Administration Schedule | 2 | 2019 | 2324 | 0.22 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.21 | Why? |
| Intercellular Adhesion Molecule-1 | 1 | 2021 | 189 | 0.21 | Why? |
| Dose-Response Relationship, Drug | 3 | 2019 | 3776 | 0.21 | Why? |
| Thyrotropin | 2 | 2019 | 262 | 0.20 | Why? |
| Endodeoxyribonucleases | 1 | 2020 | 149 | 0.20 | Why? |
| Registries | 3 | 2018 | 12327 | 0.19 | Why? |
| Palmitates | 1 | 2018 | 4 | 0.19 | Why? |
| Spermatozoa | 1 | 2021 | 244 | 0.19 | Why? |
| Human Migration | 1 | 2020 | 133 | 0.18 | Why? |
| Mice, Inbred C57BL | 3 | 2018 | 5542 | 0.18 | Why? |
| p21-Activated Kinases | 1 | 2017 | 14 | 0.18 | Why? |
| Ubiquitin-Conjugating Enzymes | 1 | 2018 | 27 | 0.18 | Why? |
| Mice, Inbred NOD | 1 | 2018 | 134 | 0.18 | Why? |
| Inflammation | 2 | 2020 | 13255 | 0.18 | Why? |
| Caveolin 1 | 1 | 2018 | 73 | 0.18 | Why? |
| Cell Cycle Proteins | 1 | 2020 | 297 | 0.18 | Why? |
| Gene Expression Regulation | 3 | 2021 | 4020 | 0.18 | Why? |
| Insulin Detemir | 1 | 2017 | 10 | 0.18 | Why? |
| Insulin, Isophane | 1 | 2017 | 23 | 0.18 | Why? |
| Acarbose | 1 | 2017 | 4 | 0.17 | Why? |
| CRISPR-Associated Proteins | 1 | 2020 | 258 | 0.17 | Why? |
| Insulin, Long-Acting | 1 | 2017 | 30 | 0.17 | Why? |
| Lab-On-A-Chip Devices | 1 | 2021 | 411 | 0.17 | Why? |
| Humans | 44 | 2021 | 930598 | 0.17 | Why? |
| RNA, Ribosomal, 16S | 1 | 2020 | 793 | 0.17 | Why? |
| China | 11 | 2021 | 50654 | 0.17 | Why? |
| Oligonucleotide Array Sequence Analysis | 1 | 2018 | 343 | 0.16 | Why? |
| Sulfonylurea Compounds | 1 | 2017 | 79 | 0.16 | Why? |
| Fibroblast Growth Factors | 1 | 2017 | 119 | 0.15 | Why? |
| Albuminuria | 1 | 2017 | 164 | 0.15 | Why? |
| Cardiovascular Diseases | 1 | 2021 | 11497 | 0.15 | Why? |
| Male | 27 | 2021 | 367725 | 0.15 | Why? |
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2020 | 624 | 0.15 | Why? |
| Semen | 1 | 2021 | 550 | 0.15 | Why? |
| Betacoronavirus | 7 | 2020 | 204454 | 0.15 | Why? |
| Blood Pressure | 2 | 2017 | 2198 | 0.15 | Why? |
| Mice, Knockout | 2 | 2018 | 1815 | 0.15 | Why? |
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2020 | 581 | 0.14 | Why? |
| Nuclear Proteins | 1 | 2017 | 321 | 0.14 | Why? |
| Models, Immunological | 1 | 2020 | 727 | 0.14 | Why? |
| Female | 22 | 2021 | 380317 | 0.14 | Why? |
| Thyroid Diseases | 1 | 2018 | 285 | 0.14 | Why? |
| Random Allocation | 1 | 2017 | 773 | 0.14 | Why? |
| Glucose | 1 | 2018 | 573 | 0.14 | Why? |
| Intestines | 1 | 2020 | 817 | 0.13 | Why? |
| Polyphenols | 1 | 2017 | 283 | 0.13 | Why? |
| Quarantine | 1 | 2021 | 18418 | 0.13 | Why? |
| Inflammasomes | 1 | 2020 | 710 | 0.13 | Why? |
| Population Health | 1 | 2020 | 504 | 0.13 | Why? |
| Energy Metabolism | 1 | 2017 | 451 | 0.13 | Why? |
| Publications | 1 | 2018 | 463 | 0.13 | Why? |
| Carbamates | 1 | 2017 | 485 | 0.13 | Why? |
| Adult | 17 | 2021 | 244371 | 0.13 | Why? |
| Cholesterol, LDL | 1 | 2017 | 499 | 0.12 | Why? |
| Pneumonia, Viral | 7 | 2020 | 243684 | 0.12 | Why? |
| Body Weight | 1 | 2019 | 1074 | 0.12 | Why? |
| Coronavirus Infections | 7 | 2020 | 253789 | 0.12 | Why? |
| Linear Models | 1 | 2019 | 1914 | 0.12 | Why? |
| Case-Control Studies | 3 | 2021 | 17671 | 0.12 | Why? |
| Molecular Targeted Therapy | 1 | 2021 | 1579 | 0.12 | Why? |
| Ecosystem | 1 | 2017 | 776 | 0.11 | Why? |
| Middle Aged | 14 | 2021 | 270681 | 0.11 | Why? |
| Bacterial Proteins | 1 | 2020 | 1318 | 0.11 | Why? |
| Child, Preschool | 3 | 2021 | 36283 | 0.11 | Why? |
| Models, Biological | 2 | 2020 | 4907 | 0.11 | Why? |
| Animals | 9 | 2018 | 78931 | 0.11 | Why? |
| Nucleocapsid Proteins | 2 | 2020 | 3120 | 0.11 | Why? |
| Remission Induction | 1 | 2014 | 950 | 0.11 | Why? |
| Apoptosis | 2 | 2018 | 2335 | 0.11 | Why? |
| Piperidines | 1 | 2017 | 795 | 0.10 | Why? |
| Child | 4 | 2021 | 70012 | 0.10 | Why? |
| Cost of Illness | 2 | 2018 | 1903 | 0.10 | Why? |
| Patient Preference | 1 | 2017 | 750 | 0.10 | Why? |
| Adolescent | 6 | 2021 | 86841 | 0.10 | Why? |
| Health Care Costs | 1 | 2018 | 1007 | 0.10 | Why? |
| Iodide Peroxidase | 2 | 2018 | 19 | 0.10 | Why? |
| Cells, Cultured | 2 | 2018 | 5835 | 0.10 | Why? |
| Diabetic Ketoacidosis | 1 | 2017 | 622 | 0.09 | Why? |
| Drug Therapy, Combination | 3 | 2017 | 7268 | 0.09 | Why? |
| Sensitivity and Specificity | 3 | 2021 | 22971 | 0.09 | Why? |
| Immunoglobulin A | 1 | 2020 | 3567 | 0.09 | Why? |
| Pandemics | 9 | 2021 | 389249 | 0.09 | Why? |
| Carrier State | 1 | 2020 | 2100 | 0.09 | Why? |
| Age Distribution | 1 | 2018 | 3567 | 0.09 | Why? |
| Monocytes | 1 | 2020 | 2978 | 0.09 | Why? |
| Multivariate Analysis | 1 | 2019 | 5440 | 0.09 | Why? |
| Mice | 5 | 2018 | 21357 | 0.09 | Why? |
| Young Adult | 7 | 2020 | 93724 | 0.08 | Why? |
| Glucose Tolerance Test | 2 | 2018 | 238 | 0.08 | Why? |
| Autoantibodies | 1 | 2018 | 2094 | 0.08 | Why? |
| Drug Discovery | 1 | 2021 | 3092 | 0.08 | Why? |
| Quality of Health Care | 1 | 2018 | 1948 | 0.08 | Why? |
| Gene Expression Profiling | 1 | 2018 | 3788 | 0.08 | Why? |
| Signal Transduction | 3 | 2018 | 7207 | 0.08 | Why? |
| Infant | 2 | 2020 | 30274 | 0.08 | Why? |
| Hep G2 Cells | 2 | 2017 | 391 | 0.08 | Why? |
| Motivation | 1 | 2017 | 1640 | 0.08 | Why? |
| Diabetes Complications | 1 | 2018 | 2358 | 0.08 | Why? |
| Treatment Outcome | 5 | 2021 | 51732 | 0.08 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 7868 | 0.07 | Why? |
| Proto-Oncogene Proteins c-akt | 2 | 2018 | 372 | 0.07 | Why? |
| Age Factors | 3 | 2021 | 21039 | 0.07 | Why? |
| Congresses as Topic | 1 | 2014 | 1347 | 0.07 | Why? |
| Patient Discharge | 1 | 2020 | 5696 | 0.07 | Why? |
| Immunologic Factors | 1 | 2020 | 4206 | 0.07 | Why? |
| Time Factors | 4 | 2021 | 31397 | 0.06 | Why? |
| Biomarkers | 2 | 2018 | 23361 | 0.06 | Why? |
| Immunoglobulin M | 1 | 2020 | 9091 | 0.06 | Why? |
| Asthenozoospermia | 1 | 2021 | 18 | 0.06 | Why? |
| Liver | 1 | 2017 | 4007 | 0.06 | Why? |
| Interleukin-6 | 1 | 2020 | 7522 | 0.06 | Why? |
| Sperm Count | 1 | 2021 | 72 | 0.06 | Why? |
| Prospective Studies | 4 | 2021 | 43301 | 0.06 | Why? |
| Sperm Motility | 1 | 2021 | 106 | 0.06 | Why? |
| Prolactin | 1 | 2021 | 68 | 0.06 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.06 | Why? |
| Anti-Inflammatory Agents | 1 | 2020 | 6153 | 0.05 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 11367 | 0.05 | Why? |
| Progesterone | 1 | 2021 | 106 | 0.05 | Why? |
| Walking Speed | 1 | 2021 | 77 | 0.05 | Why? |
| Scattering, Small Angle | 1 | 2020 | 91 | 0.05 | Why? |
| Tertiary Care Centers | 1 | 2018 | 8248 | 0.05 | Why? |
| Semen Analysis | 1 | 2021 | 235 | 0.05 | Why? |
| Steroid 21-Hydroxylase | 1 | 2018 | 3 | 0.05 | Why? |
| Zinc Transporter 8 | 1 | 2018 | 3 | 0.05 | Why? |
| Iron-Binding Proteins | 1 | 2018 | 10 | 0.05 | Why? |
| Obesity | 2 | 2017 | 7388 | 0.05 | Why? |
| X-Ray Diffraction | 1 | 2020 | 249 | 0.05 | Why? |
| Glutamate Decarboxylase | 1 | 2018 | 25 | 0.05 | Why? |
| Infusions, Subcutaneous | 1 | 2018 | 36 | 0.05 | Why? |
| Cyclin D | 1 | 2018 | 2 | 0.05 | Why? |
| Disease Models, Animal | 1 | 2017 | 10998 | 0.05 | Why? |
| Sumoylation | 1 | 2018 | 21 | 0.05 | Why? |
| Octamer Transcription Factor-1 | 1 | 2017 | 2 | 0.05 | Why? |
| Gonadal Steroid Hormones | 1 | 2021 | 328 | 0.05 | Why? |
| Transglutaminases | 1 | 2018 | 77 | 0.05 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 9335 | 0.05 | Why? |
| Self Care | 2 | 2017 | 918 | 0.05 | Why? |
| Models, Theoretical | 1 | 2017 | 6659 | 0.04 | Why? |
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2017 | 54 | 0.04 | Why? |
| GTP-Binding Proteins | 1 | 2018 | 132 | 0.04 | Why? |
| Glucose Clamp Technique | 1 | 2017 | 39 | 0.04 | Why? |
| Lost to Follow-Up | 1 | 2017 | 79 | 0.04 | Why? |
| Polyproteins | 1 | 2020 | 814 | 0.04 | Why? |
| Iodine | 1 | 2019 | 116 | 0.04 | Why? |
| Lysine | 1 | 2018 | 153 | 0.04 | Why? |
| PPAR alpha | 1 | 2017 | 36 | 0.04 | Why? |
| Aged | 6 | 2019 | 215776 | 0.04 | Why? |
| Thyroxine | 1 | 2019 | 250 | 0.04 | Why? |
| Gene Knockout Techniques | 1 | 2017 | 347 | 0.04 | Why? |
| Islets of Langerhans | 1 | 2018 | 138 | 0.04 | Why? |
| Reference Standards | 1 | 2020 | 1163 | 0.04 | Why? |
| Infant, Newborn | 1 | 2018 | 23105 | 0.04 | Why? |
| Immunoglobulin G | 1 | 2020 | 21571 | 0.04 | Why? |
| Autoantigens | 1 | 2018 | 388 | 0.04 | Why? |
| RNA, Viral | 2 | 2020 | 32276 | 0.04 | Why? |
| Phosphatidylinositol 3-Kinases | 1 | 2018 | 347 | 0.04 | Why? |
| Reference Values | 1 | 2018 | 795 | 0.04 | Why? |
| Incidence | 1 | 2018 | 25622 | 0.04 | Why? |
| Protein Structure, Tertiary | 1 | 2020 | 1565 | 0.04 | Why? |
| Intention to Treat Analysis | 1 | 2017 | 673 | 0.04 | Why? |
| Nucleic Acids | 1 | 2020 | 435 | 0.04 | Why? |
| Prognosis | 1 | 2019 | 32490 | 0.04 | Why? |
| Age of Onset | 1 | 2017 | 557 | 0.04 | Why? |
| Nasal Cavity | 1 | 2020 | 909 | 0.04 | Why? |
| RNA Interference | 1 | 2018 | 534 | 0.04 | Why? |
| Drug Resistance | 1 | 2017 | 395 | 0.03 | Why? |
| Comorbidity | 1 | 2019 | 34796 | 0.03 | Why? |
| Protein Multimerization | 1 | 2020 | 1336 | 0.03 | Why? |
| NF-E2-Related Factor 2 | 1 | 2018 | 373 | 0.03 | Why? |
| Tomography, X-Ray Computed | 1 | 2021 | 25144 | 0.03 | Why? |
| Beijing | 1 | 2017 | 912 | 0.03 | Why? |
| RNA, Small Interfering | 1 | 2018 | 817 | 0.03 | Why? |
| Insurance Coverage | 1 | 2017 | 348 | 0.03 | Why? |
| Public Health | 1 | 2018 | 16359 | 0.03 | Why? |
| Limit of Detection | 1 | 2020 | 2698 | 0.03 | Why? |
| Receptors, Interleukin-6 | 1 | 2020 | 1383 | 0.03 | Why? |
| Weight Gain | 1 | 2017 | 552 | 0.03 | Why? |
| Reactive Oxygen Species | 1 | 2018 | 1136 | 0.03 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.03 | Why? |
| Communicable Disease Control | 1 | 2021 | 29620 | 0.03 | Why? |
| Insurance, Health | 1 | 2017 | 634 | 0.03 | Why? |
| Metabolic Diseases | 1 | 2017 | 505 | 0.03 | Why? |
| Administration, Oral | 1 | 2018 | 2340 | 0.03 | Why? |
| Phytotherapy | 1 | 2017 | 743 | 0.03 | Why? |
| Cell Proliferation | 1 | 2018 | 1973 | 0.03 | Why? |
| Cross-Sectional Studies | 4 | 2019 | 53120 | 0.03 | Why? |
| Practice Guidelines as Topic | 1 | 2014 | 15421 | 0.03 | Why? |
| Phosphoproteins | 1 | 2020 | 4346 | 0.03 | Why? |
| Single-Cell Analysis | 1 | 2020 | 2450 | 0.02 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.02 | Why? |
| Drug Monitoring | 1 | 2017 | 1408 | 0.02 | Why? |
| Macrophages | 1 | 2020 | 2784 | 0.02 | Why? |
| Research | 1 | 2021 | 2115 | 0.02 | Why? |
| Antiviral Agents | 1 | 2021 | 41703 | 0.02 | Why? |
| Antioxidants | 1 | 2018 | 1593 | 0.02 | Why? |
| Antibodies, Viral | 4 | 2021 | 51949 | 0.02 | Why? |
| Phenotype | 1 | 2018 | 4037 | 0.02 | Why? |
| Patient Education as Topic | 1 | 2017 | 1476 | 0.02 | Why? |
| Patient Compliance | 1 | 2017 | 1468 | 0.02 | Why? |
| Feces | 1 | 2020 | 4235 | 0.02 | Why? |
| Oxidative Stress | 1 | 2018 | 2050 | 0.02 | Why? |
| Prevalence | 2 | 2018 | 25773 | 0.02 | Why? |
| Risk | 1 | 2018 | 5288 | 0.02 | Why? |
| Nucleic Acid Amplification Techniques | 1 | 2020 | 3388 | 0.02 | Why? |
| B-Lymphocytes | 1 | 2020 | 4418 | 0.02 | Why? |
| Autoimmune Diseases | 1 | 2018 | 1996 | 0.02 | Why? |
| Diet | 1 | 2017 | 2052 | 0.02 | Why? |
| Computational Biology | 1 | 2020 | 4514 | 0.02 | Why? |
| HEK293 Cells | 1 | 2018 | 8394 | 0.02 | Why? |
| Radiography, Thoracic | 1 | 2021 | 5486 | 0.02 | Why? |
| Protein Binding | 1 | 2020 | 11430 | 0.02 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2020 | 5837 | 0.02 | Why? |
| Viral Proteins | 1 | 2020 | 7370 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2018 | 17020 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2018 | 88759 | 0.01 | Why? |
| Lung | 1 | 2021 | 31049 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2017 | 43792 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2017 | 48226 | 0.01 | Why? |